Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Conexeu Sciences Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
CNXU
Nasdaq
2836
www.conexeu.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Conexeu Sciences Inc.
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration
- Aug 11th, 2026 6:30 am
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
- Aug 3rd, 2026 8:55 am
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
- Jul 14th, 2026 6:30 am
A $190 Billion Weight-Loss Boom Has Exposed a Tissue-Restoration Gap Today’s Injectables Were Not Built to Fill
- Jul 7th, 2026 7:00 am
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
- Jun 25th, 2026 6:30 am
Is Conexeu Sciences (CNXU) Quietly Redefining Its Commercial Ambitions With CXU Platform Moves?
- Jun 19th, 2026 12:16 am
Conexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listing
- Jun 15th, 2026 6:30 am
Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program
- Jun 8th, 2026 6:30 am
Before the IPO: 4 Companies That Rewarded Investors Who Got In Early
- Jun 4th, 2026 8:50 am
Conexeu Sciences to Ring Nasdaq Bell on June 10, 2026
- Jun 3rd, 2026 6:30 am
How Investors Are Reacting To Conexeu Sciences (CNXU) 3D-Printed Bioregenerative Breast Matrix Initiative
- Jun 2nd, 2026 4:10 am
UPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicine
- May 27th, 2026 8:36 am
Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
- May 21st, 2026 10:02 am
Scroll